BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2645537)

  • 1. Specific imaging of dialysis-related amyloid deposits using 131I-beta-2-microglobulin.
    Floege J; Nonnast-Daniel B; Gielow P; Brandis A; Spindler E; Hundeshagen H; Koch KM; Shaldon S
    Nephron; 1989; 51(3):444-7. PubMed ID: 2645537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synovial inflammatory cells captured 131I-beta 2-microglobulin in patients with dialysis related amyloidosis.
    Kazama JJ; Arakawa M; Gejyo F
    Amyloid; 1998 Mar; 5(1):24-9. PubMed ID: 9547002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging of dialysis-related amyloid (AB-amyloid) deposits with 131I-beta 2-microglobulin.
    Floege J; Burchert W; Brandis A; Gielow P; Nonnast-Daniel B; Spindler E; Hundeshagen H; Shaldon S; Koch KM
    Kidney Int; 1990 Dec; 38(6):1169-76. PubMed ID: 2074658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 131I-beta 2-microglobulin scintigraphy in patients with dialysis amyloidosis.
    Gejyo F; Kazama JJ; Hasegawa S; Nishi S; Arakawa M; Odano I
    Clin Nephrol; 1995 Nov; 44 Suppl 1():S14-8. PubMed ID: 8608655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymerization of intact beta 2-microglobulin in tissue causes amyloidosis in patients on chronic hemodialysis.
    Gorevic PD; Munoz PC; Casey TT; DiRaimondo CR; Stone WJ; Prelli FC; Rodrigues MM; Poulik MD; Frangione B
    Proc Natl Acad Sci U S A; 1986 Oct; 83(20):7908-12. PubMed ID: 3532124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dialysis related amyloidosis: a disease of chronic retention and inflammation?
    Floege J; Schäffer J; Koch KM; Shaldon S
    Kidney Int Suppl; 1992 Oct; 38():S78-85. PubMed ID: 1405384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging of haemodialysis-associated amyloidosis with 123I-serum amyloid P component.
    Nelson SR; Hawkins PN; Richardson S; Lavender JP; Sethi D; Gower PE; Pugh CW; Winearls CG; Oliver DO; Pepys MB
    Lancet; 1991 Aug; 338(8763):335-9. PubMed ID: 1677697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Scintigraphy of iodine 123 labelled serum amyloid P component in beta 2-microglobulin amyloidosis of hemodialysis].
    Flipo RM; Deveaux M; Duneton O; Foissac-Gegoux P; Dumont A; Duquesnoy B; Marchandise X
    Nephrologie; 1995; 16(6):419-25. PubMed ID: 8524449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic approaches to AB-amyloidosis.
    Floege J
    Blood Purif; 1991; 9(2):63-9. PubMed ID: 1760143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging techniques in the diagnosis of dialysis-related amyloidosis.
    Ketteler M; Koch KM; Floege J
    Semin Dial; 2001; 14(2):90-3. PubMed ID: 11264773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of pentosidine as a native structure for advanced glycation end products in beta-2-microglobulin-containing amyloid fibrils in patients with dialysis-related amyloidosis.
    Miyata T; Taneda S; Kawai R; Ueda Y; Horiuchi S; Hara M; Maeda K; Monnier VM
    Proc Natl Acad Sci U S A; 1996 Mar; 93(6):2353-8. PubMed ID: 8637877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis and management of dialysis-related amyloid bone disease.
    Nangaku M; Miyata T; Kurokawa K
    Am J Med Sci; 1999 Jun; 317(6):410-5. PubMed ID: 10372842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta 2-microglobulin amyloidosis in hemodialysis patients. An autopsy study of intervertebral disks and posterior longitudinal ligaments.
    Honda K; Hara M; Ogura Y; Nihei H; Mimura N
    Acta Pathol Jpn; 1990 Nov; 40(11):820-6. PubMed ID: 2127652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Historical background and clinical treatment of dialysis-related amyloidosis.
    Yamamoto S; Gejyo F
    Biochim Biophys Acta; 2005 Nov; 1753(1):4-10. PubMed ID: 16226497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scintigraphic methods to detect beta2-microglobulin associated amyloidosis (Abeta2-microglobulin amyloidosis).
    Floege J; Schäffer J; Koch KM
    Nephrol Dial Transplant; 2001; 16 Suppl 4():12-6. PubMed ID: 11402091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis, pathogenesis, and treatment of dialysis-related amyloidosis.
    Miyata T; Inagi R; Kurokawa K
    Miner Electrolyte Metab; 1999; 25(1-2):114-7. PubMed ID: 10207272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum amyloid P component: a predictor of clinical beta 2-microglobulin amyloidosis.
    Spiegel DM; Sprague SM
    Am J Kidney Dis; 1992 May; 19(5):427-32. PubMed ID: 1585929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Beta-2 microglobulin and amyloid osteoarthropathy in patients undergoing chronic hemodialysis].
    Prinseau J; Baglin A; Benoit J; Leparc JM; Got C; Louis MF; Attar B; Fritel D
    Ann Med Interne (Paris); 1989; 140(2):94-8. PubMed ID: 2662855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mediators of amyloidogenesis and cytokines in dialysis-related amyloidosis].
    Rysavá R; Merta M; Tesar V; Lachmanová J; Sulková S; Bláha J
    Cas Lek Cesk; 2002 Apr; 141(8):244-7. PubMed ID: 12038073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcutaneous amyloid-tumor of beta-2-microglobulin origin in a long-term hemodialysis patient.
    Floege J; Brandis A; Nonnast-Daniel B; Westhoff-Bleck M; Tiedow G; Linke RP; Koch KM
    Nephron; 1989; 53(1):73-5. PubMed ID: 2674745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.